West Announces Second-Quarter Dividend
West Pharmaceutical Services (NYSE: WST) has announced its second-quarter 2025 dividend payment. The company's Board of Directors has approved a dividend of $0.21 per share, which will be paid on May 7, 2025, to shareholders of record as of April 30, 2025. West Pharmaceutical Services is recognized as a global leader in innovative solutions for injectable drug administration.
West Pharmaceutical Services (NYSE: WST) ha annunciato il pagamento del dividendo per il secondo trimestre del 2025. Il Consiglio di Amministrazione dell'azienda ha approvato un dividendo di $0,21 per azione, che sarà pagato il 7 maggio 2025, agli azionisti registrati al 30 aprile 2025. West Pharmaceutical Services è riconosciuta come leader globale nelle soluzioni innovative per la somministrazione di farmaci iniettabili.
West Pharmaceutical Services (NYSE: WST) ha anunciado el pago de dividendos para el segundo trimestre de 2025. La Junta Directiva de la compañía ha aprobado un dividendo de $0.21 por acción, que se pagará el 7 de mayo de 2025, a los accionistas registrados hasta el 30 de abril de 2025. West Pharmaceutical Services es reconocida como líder global en soluciones innovadoras para la administración de medicamentos inyectables.
웨스트 제약 서비스 (NYSE: WST)는 2025년 2분기 배당금 지급을 발표했습니다. 회사의 이사회는 주당 $0.21의 배당금을 승인했으며, 이는 2025년 5월 7일에 지급될 예정입니다. 배당금 지급 기준일은 2025년 4월 30일입니다. 웨스트 제약 서비스는 주사 약물 투여를 위한 혁신적 솔루션에서 세계적인 리더로 인정받고 있습니다.
West Pharmaceutical Services (NYSE: WST) a annoncé le paiement de son dividende pour le deuxième trimestre 2025. Le Conseil d'administration de l'entreprise a approuvé un dividende de 0,21 $ par action, qui sera versé le 7 mai 2025, aux actionnaires enregistrés au 30 avril 2025. West Pharmaceutical Services est reconnue comme un leader mondial dans les solutions innovantes pour l'administration de médicaments injectables.
West Pharmaceutical Services (NYSE: WST) hat die Dividendenzahlung für das zweite Quartal 2025 bekannt gegeben. Der Vorstand des Unternehmens hat eine Dividende von 0,21 $ pro Aktie genehmigt, die am 7. Mai 2025 an die Aktionäre ausgezahlt wird, die am 30. April 2025 im Aktienregister stehen. West Pharmaceutical Services ist als globaler Marktführer in innovativen Lösungen für die Verabreichung von injizierbaren Arzneimitteln anerkannt.
- Consistent dividend payment demonstrates financial stability
- Maintains shareholder returns through quarterly dividend program
- None.
About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites including 25 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year.
Headquartered in
All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.
View original content to download multimedia:https://www.prnewswire.com/news-releases/west-announces-second-quarter-dividend-302381862.html
SOURCE West Pharmaceutical Services, Inc.
FAQ
What is West Pharmaceutical Services' dividend amount for Q2 2025?
When is the ex-dividend date for WST's Q2 2025 dividend?
When will WST pay its Q2 2025 dividend?
Who is eligible for WST's Q2 2025 dividend payment?
